Cargando…

Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls

INTRODUCTION: Polyneuropathy is a debilitating condition characterized by distal sensory and motor deficits. Schwann cell dysfunction and axonal loss are integral factors in pathophysiology and disease progression of polyneuropathy. AIMS: The aim of this study was the assessment of Schwann cell char...

Descripción completa

Detalles Bibliográficos
Autores principales: Placheta-Györi, Eva, Brandstetter, Lea Maria, Zemann-Schälss, Jakob, Wolf, Sonja, Radtke, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568174/
https://www.ncbi.nlm.nih.gov/pubmed/34735549
http://dx.doi.org/10.1371/journal.pone.0259654
_version_ 1784594379909890048
author Placheta-Györi, Eva
Brandstetter, Lea Maria
Zemann-Schälss, Jakob
Wolf, Sonja
Radtke, Christine
author_facet Placheta-Györi, Eva
Brandstetter, Lea Maria
Zemann-Schälss, Jakob
Wolf, Sonja
Radtke, Christine
author_sort Placheta-Györi, Eva
collection PubMed
description INTRODUCTION: Polyneuropathy is a debilitating condition characterized by distal sensory and motor deficits. Schwann cell dysfunction and axonal loss are integral factors in pathophysiology and disease progression of polyneuropathy. AIMS: The aim of this study was the assessment of Schwann cell characteristics, nerve fibers and myelination parameters in polyneuropathy patients compared to controls. METHODS: Nerve tissue was obtained from polyneuropathy patients (n = 10) undergoing diagnostic sural nerve biopsies. Biopsies of healthy peripheral nerves (n = 5) were harvested during elective sural nerve grafting for chronic peripheral nerve lesions. Exclusion criteria for the healthy control group were recent neurological trauma, diabetes, neurological and cardiovascular disease, as well as active malignancies and cytotoxic medication within the last 12 months. The over-all architecture of nerve sections and myelination parameters were histomorphometrically analyzed. Immunofluorescent imaging was used to evaluate Schwann cell phenotypes, senescence markers and myelination parameters. RESULTS: Histomorphometric analysis of nerve biopsies showed significant axonal loss in polyneuropathy patients compared to controls, which was in accordance with the neuropathological findings. Immunofluorescent staining of Schwann cells and myelin basic protein indicated a significant impairment of myelination and lower Schwann cell counts compared to controls. Phenotypic alterations and increased numbers of non-myelinating p75-positive Schwann cells were found in polyneuropathy patients. DISCUSSION: This study provided quantitative data of axonal loss, reduced myelination and Schwann cell dysfunction of polyneuropathy patients compared to neurologically healthy controls. Phenotypic alterations of Schwann cells were similar to those seen after peripheral nerve injury, highlighting the clinical relevance of Schwann cell dysfunction.
format Online
Article
Text
id pubmed-8568174
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-85681742021-11-05 Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls Placheta-Györi, Eva Brandstetter, Lea Maria Zemann-Schälss, Jakob Wolf, Sonja Radtke, Christine PLoS One Research Article INTRODUCTION: Polyneuropathy is a debilitating condition characterized by distal sensory and motor deficits. Schwann cell dysfunction and axonal loss are integral factors in pathophysiology and disease progression of polyneuropathy. AIMS: The aim of this study was the assessment of Schwann cell characteristics, nerve fibers and myelination parameters in polyneuropathy patients compared to controls. METHODS: Nerve tissue was obtained from polyneuropathy patients (n = 10) undergoing diagnostic sural nerve biopsies. Biopsies of healthy peripheral nerves (n = 5) were harvested during elective sural nerve grafting for chronic peripheral nerve lesions. Exclusion criteria for the healthy control group were recent neurological trauma, diabetes, neurological and cardiovascular disease, as well as active malignancies and cytotoxic medication within the last 12 months. The over-all architecture of nerve sections and myelination parameters were histomorphometrically analyzed. Immunofluorescent imaging was used to evaluate Schwann cell phenotypes, senescence markers and myelination parameters. RESULTS: Histomorphometric analysis of nerve biopsies showed significant axonal loss in polyneuropathy patients compared to controls, which was in accordance with the neuropathological findings. Immunofluorescent staining of Schwann cells and myelin basic protein indicated a significant impairment of myelination and lower Schwann cell counts compared to controls. Phenotypic alterations and increased numbers of non-myelinating p75-positive Schwann cells were found in polyneuropathy patients. DISCUSSION: This study provided quantitative data of axonal loss, reduced myelination and Schwann cell dysfunction of polyneuropathy patients compared to neurologically healthy controls. Phenotypic alterations of Schwann cells were similar to those seen after peripheral nerve injury, highlighting the clinical relevance of Schwann cell dysfunction. Public Library of Science 2021-11-04 /pmc/articles/PMC8568174/ /pubmed/34735549 http://dx.doi.org/10.1371/journal.pone.0259654 Text en © 2021 Placheta-Györi et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Placheta-Györi, Eva
Brandstetter, Lea Maria
Zemann-Schälss, Jakob
Wolf, Sonja
Radtke, Christine
Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls
title Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls
title_full Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls
title_fullStr Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls
title_full_unstemmed Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls
title_short Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls
title_sort myelination, axonal loss and schwann cell characteristics in axonal polyneuropathy compared to controls
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568174/
https://www.ncbi.nlm.nih.gov/pubmed/34735549
http://dx.doi.org/10.1371/journal.pone.0259654
work_keys_str_mv AT plachetagyorieva myelinationaxonallossandschwanncellcharacteristicsinaxonalpolyneuropathycomparedtocontrols
AT brandstetterleamaria myelinationaxonallossandschwanncellcharacteristicsinaxonalpolyneuropathycomparedtocontrols
AT zemannschalssjakob myelinationaxonallossandschwanncellcharacteristicsinaxonalpolyneuropathycomparedtocontrols
AT wolfsonja myelinationaxonallossandschwanncellcharacteristicsinaxonalpolyneuropathycomparedtocontrols
AT radtkechristine myelinationaxonallossandschwanncellcharacteristicsinaxonalpolyneuropathycomparedtocontrols